|
Market Closed -
Nasdaq Stockholm
17:00:00 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.790 SEK | +3.17% |
|
+5.92% | -5.79% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 434M 386M 360M 328M 619M 41.84B 625M 4.36B 1.69B 21.34B 1.63B 1.6B 68.58B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 402M 358M 333M 304M 573M 38.75B 579M 4.04B 1.57B 19.76B 1.51B 1.48B 63.51B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 day | +3.17% | ||
| 1 week | +5.92% | ||
| Current month | +4.68% | ||
| 1 month | -2.45% | ||
| 3 months | -25.42% | ||
| 6 months | -40.33% | ||
| Current year | -5.79% |
| 1 week | 1.6 |  | 1.79 |
| 1 month | 1.55 | | 2.22 |
| Current year | 1.55 | | 3.4 |
| 1 year | 1.55 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 31/01/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 12/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 26/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 14/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 18/12/2016 |
| Director/Board Member | 71 | 18/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 01/04/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.17% | +5.92% | -24.79% | -47.20% | 41.91M | |
| -0.61% | -3.30% | +38.46% | +112.77% | 1,025B | |
| -1.02% | -5.41% | +37.61% | +64.39% | 623B | |
| +1.11% | -0.87% | +7.55% | +76.32% | 459B | |
| +0.34% | -2.49% | +60.10% | +40.17% | 355B | |
| -0.95% | -4.87% | +22.46% | +38.03% | 336B | |
| -1.46% | -2.20% | +11.84% | +23.94% | 270B | |
| -1.35% | -4.27% | -4.55% | +6.92% | 247B | |
| -1.04% | -0.74% | +35.02% | +49.96% | 220B | |
| -1.87% | -3.31% | +30.22% | +93.14% | 183B | |
| Average | +0.08% | -1.44% | +21.39% | +45.84% | 371.83B | |
| Weighted average by Cap. | -0.00% | -2.11% | +29.72% | +68.31% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 40.51M 37.76M 34.42M 64.92M 4.39B 65.55M 458M 177M 2.24B 171M 167M 7.19B | 53.9M 47.91M 44.66M 40.71M 76.78M 5.19B 77.52M 541M 210M 2.65B 202M 198M 8.51B |
| Net income | -53.18M -47.27M -44.06M -40.16M -75.75M -5.12B -76.48M -534M -207M -2.61B -200M -195M -8.39B | -51.89M -46.12M -42.99M -39.19M -73.92M -5B -74.63M -521M -202M -2.55B -195M -191M -8.19B |
| Net Debt | -73.01M -64.89M -60.49M -55.14M -104M -7.03B -105M -733M -284M -3.59B -274M -268M -11.52B | -32.11M -28.54M -26.6M -24.25M -45.74M -3.09B -46.18M -322M -125M -1.58B -121M -118M -5.07B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | SEK 1.790 | +3.17% | 24,436 |
| 01/10/26 | SEK 1.735 | +1.46% | 98,369 |
| 30/09/26 | SEK 1.710 | -0.87% | 32,140 |
| 29/09/26 | SEK 1.725 | -0.29% | 83,464 |
| 28/09/26 | SEK 1.730 | +3.90% | 49,134 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
